Pfizer seeks Canada’s approval for Covid-19 vaccine for children aged five to 12 years
The regulatory submission is based on data from the Phase 2/3 study of the Comirnaty 10μg dose in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Oct 21
The regulatory submission is based on data from the Phase 2/3 study of the Comirnaty 10μg dose in…
18 Oct 21
The FDA approval is based on the Phase 3 IMpower010 study, which showed that adjuvant Tecentriq improved disease-free…
18 Oct 21
The recommendation is based on results from two clinical trials, including the Phase 3 ENSEMBLE 2 study, and…
14 Oct 21
The US FDA approved Verzenio based on results from Phase 3 monarchE trial in adults with HR+ HER2-,…
14 Oct 21
The FDA approval is based on the Phase 3 KEYNOTE-826 trial, which showed superior overall survival and progression-free…
12 Oct 21
Merck’s regulatory submission for molnupiravir is based on positive results from the interim analysis of Phase 3 MOVe-OUT…
12 Oct 21
Gantenerumab is an investigational IgG1 antibody designed to block certain forms of amyloid beta and eliminate brain amyloid…
11 Oct 21
The company claims that Tavneos is the first orally-administered inhibitor of the complement 5a receptor to receive the…
06 Oct 21
The company’s submission of antibody cocktail is based on safety and efficacy data from the Phase 3 PROVENT…
05 Oct 21
The US FDA has granted BTD for Enhertu based on results from the DESTINY-Breast03 trial, in which Enhertu…